Table 2.
Patient | Diagnosis | Imaging progression (months, following SRS) | Outcome |
---|---|---|---|
1 | JPA recurrence | PD → PR (at 17) → CR (at 20) | CR as of last f/u |
2 | SD → PD (at 4) → Failed | Local failure | |
3 | JPA residual | SD → PD (at 15) → Failed | Local failure |
4 | SD → PD (at 7) → SD (at 11) | SD as of last f/u | |
5 | MB recurrence | CR (at 2) | CR as of last f/u |
5 | |||
5 | |||
6 | PR → CR (at 4) | ||
6 | |||
6 | |||
6 | |||
7 | MB metastasis | SD → CR (at 6) | CR as of last f/u |
8 | CR (at 2) | ||
8 | |||
8 | SD (at 2) | SD as of last f/u | |
8 | |||
9 | EM recurrence | SD → PD (at 8) → Failed | Local failure |
10 | PD (at 3) → Failed | ||
11 | ATRT recurrence | SD → PD (at 4) → CR (at 10) | CR as of last f/u |
11 | SD → PD (at 20) → Failed | Local Failure | |
12 | Pineocytoma | CR (at 3) | CR as of last f/u |
SD stable disease, PD progressive disease, CR complete response, PR partial response, MB medulloblastoma, JPA juvenile pilocytic astrocytoma, EM ependymoma, ATRT atypical rhabdoid teratoid tumor, f/u follow-up